NanoViricides Inc/ US6300873022 /
| 12/6/2024 10:10:00 PM | Chg. +0.0400 | Volume | Bid12:08:55 AM | Ask12:08:55 AM | High | Low |
|---|---|---|---|---|---|---|
| 1.5000USD | +2.74% | 129,380 Turnover: 176,873.5599 |
1.4900Bid Size: 100 | 1.5400Ask Size: 3,000 | 1.5300 | 1.4400 |
GlobeNewswire
8/6
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antivi...
Newsfile Corp
9/27/2021
NanoViricides, Inc. Invites You to Join Us at the Benzinga Healthcare Small Cap Conference for Updat...
GlobeNewswire
9/14/2021
Scopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Appointments of John Rossi, Ph.D. and ...
GlobeNewswire
7/21/2020
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds NanoViricides (NNVC) Investors of Proprietary Inves...
GlobeNewswire
7/16/2020
NanoViricides, Inc. Investors Who Purchased NNVC Securities After January 2020 And Suffered Losses G...
Newsfile Corp
3/5/2020
NanoViricides, Inc. Reports Discovery of Broad-Spectrum Virus-Binding Ligands; Expected to Counter C...
GlobeNewswire
5/31/2019
Antiviral Therapeutics Markets, Technologies, & Competitive Landscape 2019 Featuring 194 Companies w...
GlobeNewswire
2/26/2019
Influenza A Virus H7N9 Infection Drug Pipeline Study, H2 2018 - Analysis of Phases, Companies, Mecha...
GlobeNewswire
2/13/2019
Global Antiviral Therapeutics Technologies, Markets & Companies Report 2019: Vaccines, Pharmaceutica...
GlobeNewswire
8/21/2018
President and Chairman of the Board of Directors, Anil R. Diwan, Ph.D., of NanoViricides, Inc., Disc...
GlobeNewswire
5/10/2018
Antiviral Therapeutics Research Report 2018: Technologies, Markets and Companies 2017-2027 - Profile...
